MEDINDIA
English
हिन्दी
Español
français
中文
Pitavastatin tablets to reduce cholesterol has received tentative approval from the United States Food and Drug Administration (USFDA).
Indian Arm Of Pharma Major Gets USFDA Approval To Market Birth Control Pill
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
Lupin has received final approval from the US health regulator for marketing Norgestimate and Ethinyl Estradiol tablets in the US market.
TOP INSIGHT
Cholesterol-lowering Pitavastatin tablets from Lupin Pharmaceuticals has received the United Stated Food and Drug Administration (USFDA) approval.
Source-IANS
High Cholesterol | Hypercholesterolemia - Causes, Symptoms, Diagnosis & Treatment
High cholesterol level in blood are a risk for heart disease and stroke. They get deposited in the wall of the arteries and clog the circulation posing a threat to life.
High cholesterol level in blood are a risk for heart disease and stroke. They get deposited in the wall of the arteries and clog the circulation posing a threat to life.
Lupin Gets FDA Approval to Market Generic Birth Control Pills in US
Lupin Pharmaceuticals has finally received the approval from the USFDA to market its oral contraceptive pills in the United States.
Lupin Pharmaceuticals has finally received the approval from the USFDA to market its oral contraceptive pills in the United States.
FDA Approval for Generic Rosuvastatin
FDA approves a generic form of rosuvastatin which is potent in controlling lipid levels in the blood and is cost effective.
FDA approves a generic form of rosuvastatin which is potent in controlling lipid levels in the blood and is cost effective.
Email
